“Study of Levofloxacin and Cefoperazone-Sulbactam Utilization Cost on Patients with Mild and Moderate Corona Virus Disease- 2019: Studi Biaya Penggunaan Antibiotik Levofloxacin dan Cefoperazone-Sulbactam pada Pasien Corona Virus Disease-2019 Derajat Ringan sampai Sedang” (2024) Journal Pharmasci (Journal of Pharmacy and Science), 9(1), pp. 59–63. doi:10.53342/pharmasci.v9i1.316.